Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategy

Sanofi CEO Paul Hudson bet big on immunology. When Belén Garijo takes over as CEO next week, she will have to decide whether to continue that wager. The direction Garijo elects to pursue will likely ...